JB Chemicals Shareholders Clear Key Scheme Resolution at Court-Convened Meeting

The latest update is out from JB Chemicals & Pharmaceuticals Ltd. ( (IN:JBCHEPHARM) ).

JB Chemicals & Pharmaceuticals Ltd. has reported that its equity shareholders approved a proposed corporate Scheme at a court-convened general meeting held via video conferencing on April 28, 2026. The resolution received the required majority in number and three-fourths in value of participating equity shareholders, and also secured a favorable vote from public shareholders as mandated by SEBI’s current regulations.

The voting was conducted through remote e-voting and electronic voting during the meeting, and the scrutinizer’s report along with detailed voting results has been filed with the stock exchange. These outcomes clear a key shareholder hurdle for implementing the Scheme and will be made available on the company’s website for investors and other stakeholders to review.

More about JB Chemicals & Pharmaceuticals Ltd.

JB Chemicals & Pharmaceuticals Ltd. is an Indian pharmaceutical company engaged in the manufacture and marketing of medicines and healthcare products. The company is listed on the National Stock Exchange of India under the symbol JBCHEPHARM and serves a broad base of equity and public shareholders in the capital markets.

Average Trading Volume: 11,863

Technical Sentiment Signal: Strong Buy

Current Market Cap: 321.8B INR

See more insights into JBCHEPHARM stock on TipRanks’ Stock Analysis page.